Cellectis is a clinical-stage biopharmaceutical company focused on developing a new generation of cancer immunotherapies based on gene-edited T-cells (UCART). By capitalizing on its 18 years of expertise in gene editing – built on its flagship TALEN® technology and pioneering electroporation system PulseAgile – Cellectis uses the power of the immune system to target and eradicate cancer cells.
Using its life-science-focused, pioneering genome engineering technologies, Cellectis’ goal is to create innovative products in multiple fields and with various target markets.
Cellectis is listed on the Nasdaq market (ticker: CLLS) and on the NYSE Alternext market (ticker: ALCLS). To find out more about us, visit our website: www.cellectis.com
We are seeking for a highly motivated individual to join us as a Quality Unit Director. The successful candidate will work as part of the Pharmaceutical Compliance team of Cellectis Paris and will be responsible for the set up and management of the Quality Management System for a new GMP compliant facility in Paris dedicated to manufacture of GMP/High Quality Grade Raw and Starting Material (Plasmids, mRNA, Viral Vectors).
He/She will set-up the infrastructure, tools and QA team supporting the manufacturing and analytical activities for this project by the review and approval of quality-related documents. He/She will also line manage the Quality Control Director and advise on the QC activities.
In addition, and importantly, the Quality Unit Director will be the key driver to establish a quality culture within the company.